The CML disease is a common hematological malignancy that is caused by the uncontrollable enzymatic activity of a fusion protein known as Breakpoint Cluster Region-Abelson (BCR-ABL) [78]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.